The Precision Peptide Company Inc. News Releases

The Precision Peptide Company Announces Sponsorship of Boulderthon, Boulder Colorado's Marathon Weekend

Tue, 15 Sep 2026 07:00:00 -0400

Company to Showcase Its U.S.-Made Peptide Products at a Booth During Race Weekend, September 27, 2026 HighlightsBoulderthon 2026 takes place on Sunday, September 27, 2026, in Boulder, Colorado, finishing on the historic Pearl Street Mall.1According to race organizers, the event welcomed over 15,600 runners in 2025, a 56 percent increase over the prior year, drawing runners from all 50 states and 22 countries.3Boulderthon is a Boston Marathon Qualifying, USATF Sanctioned event named Top 10 in...

The Precision Peptide Company Announces Digital Marketing and Advertising Services Agreements

Thu, 10 Sep 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreements with (i) Senergy Communications Capital Inc. ("Senergy") and (ii) 1000903966 Ontario Inc., d.b.a. Komcore Capital ("Komcore"), to provide certain digital marketing and advertising services to the Company.SenergyThe Company has entered into a digital marketing services agreement with Senergy...

The Precision Peptide Company Advances Thymosin Alpha-1 Patch into Formal U.S. Testing

Tue, 08 Sep 2026 07:00:00 -0400

Second transdermal peptide patch expands the Company's growing portfolio across oral, topical and needle-free wellness formats HighlightsU.S. testing now underway for the Thymosin Alpha-1 transdermal patchCompletion of the testing program is targeted for Q3/Q4 of 2026Second transdermal peptide product to advance following BPC-157US$56.06 billion global peptide therapeutics market in 2026, projected to reach US$87.21 billion by 2035¹July 2026 FDA review highlights U.S. regulatory attention...

The Precision Peptide Company Announces Grants of RSUs and Stock Options

Fri, 04 Sep 2026 17:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - The Precision Peptide Company Inc. (CSE: BPC) (OTCQB: PNGAF) (the "Company") announces that on July 31, 2026, it has authorized the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan (the "Plan").The Company has granted 150,000 RSUs and 200,000 Options to a certain consultant of the Company. Each Option entitles the holder to acquire one...

The Precision Peptide Company to Showcase Its Needle-Free Recovery Patch and Supplement Range at FitExpo Anaheim

Tue, 25 Aug 2026 07:00:00 -0400

HighlightsThe Company's supplement range, led by The Recovery Patch, will be available for purchase on site at FitExpo Anaheim, August 29 and 30, 2026A 15% event discount will be available to attendees on purchases at booth 750, Anaheim Convention Center The Recovery Patch, the Company's needle-free transdermal peptide patch, achieved 95.5% chromatographic purity and a quantified 2.02 mg dose per patch in previously announced independent laboratory testingA key member of the Company's leadership...

The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch

Wed, 19 Aug 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the Company is developing a tirzepatide-based transdermal patch delivery system in the United States as an addition to its advancing product lineup.HighlightsUS$62 to 66 billion global GLP-1 market in 2025, projected to reach...

The Precision Peptide Company Completes Migration of Amino Innovations Online Store and Customer Base to Company Website

Fri, 07 Aug 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announced that it has completed the migration of the Amino Innovations online supplement store www.aminoinnovations.com (the "Amino Innovations Store"), including its product catalogue and existing customer base, onto the Company's e-commerce...

The Precision Peptide Company Targets Launch of the Peptide Pen, Expanding Its U.S.-Made Product Platform

Tue, 04 Aug 2026 08:30:00 -0400

HighlightsThe Company introduces expected launch of the Peptide Pen, its second commercial product, marking a significant expansion beyond transdermal patches into precision injection deliveryDesigned, manufactured, and tested in the United States in a cGMP-certified facility using medical-grade materialsFeatures a 5mL dosing configuration, a first for a combined pen-and-vial peptide device, offering significantly more capacity than the standard 3mL cartridges commonly availableInterchangeable...

The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review

Thu, 30 Jul 2026 07:00:00 -0400

HighlightsSeven products are now in stock and available to purchase at precisionpeptidecompany.com: BPC, KPV, Ageless, Chill, Blue, Hair and The Recovery PatchThe Recovery Patch is the Company's first transdermal peptide product available at retail, providing a needle-free format that requires no mixing, no measuring and no cold storageAll 50 U.S. states can order through the platformLegitScript Healthcare Merchant Certification supports compliance, consumer-safety, payment-processing and...

The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support

Tue, 28 Jul 2026 07:00:00 -0400

HighlightsQ3/Q4 2026 is the targeted completion period for testing of The Precision Peptide Company's Thymosin Alpha-1 transdermal patch2025 research continues to evaluate Thymosin Alpha-1 for immune regulation and inflammation, supporting its ongoing relevance within the peptide and immune-health landscape¹The patch is being developed to bring Thymosin Alpha-1 into a portable, needle-free format without mixing or cold storageBased on its review of currently publicly available products, The...